These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26704732)

  • 1. 18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis.
    Stelzmueller I; Huber H; Wunn R; Hodolic M; Mandl M; Lamprecht B; Schinko H; Fellner F; Skanjeti A; Giammarile F; Colletti PM; Rubello D; Gabriel M
    Clin Nucl Med; 2016 Apr; 41(4):e187-94. PubMed ID: 26704732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
    Martinez V; Castilla-Lievre MA; Guillet-Caruba C; Grenier G; Fior R; Desarnaud S; Doucet-Populaire F; Boué F
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1180-5. PubMed ID: 22794271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential
    Bomanji J; Sharma R; Mittal BR; Gambhir S; Qureshy A; Begum SMF; Paez D; Sathekge M; Vorster M; Sobic Saranovic D; Pusuwan P; Mann V; Vinjamuri S; Zumla A; Pascual TNB
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3118-3129. PubMed ID: 32483653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
    Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients?
    Sood A; Mittal BR; Modi M; Chhabra R; Verma R; Rana N; Parihar AS; Satapathy S; Kumar R
    Clin Nucl Med; 2020 Apr; 45(4):276-282. PubMed ID: 32108701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases.
    Zhao Z; Wang Y; Guan Z; Jin J; Huang F; Zhu J
    Clin Exp Rheumatol; 2016; 34(1):119-25. PubMed ID: 26842851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT lung 'focalities' without coregistered CT findings: an interpretative clinical dilemma.
    Chondrogiannis S; Marzola MC; Grassetto G; Zorzi A; Milan E; Rampin L; Rubello D; Colletti PM
    Nucl Med Commun; 2015 Apr; 36(4):334-9. PubMed ID: 25658717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis.
    Tian G; Xiao Y; Chen B; Xia J; Guan H; Deng Q
    Acta Radiol; 2010 Nov; 51(9):1002-6. PubMed ID: 20942732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
    J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards more accurate
    Priftakis D; Riaz S; Zumla A; Bomanji J
    Int J Infect Dis; 2020 Mar; 92S():S85-S90. PubMed ID: 32114199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging.
    Panagiotidis E; Datseris IE; Exarhos D; Skilakaki M; Skoura E; Bamias A
    Nucl Med Commun; 2012 Apr; 33(4):431-8. PubMed ID: 22293498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
    Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
    Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
    Eugene T; Corradini N; Carlier T; Dupas B; Leux C; Bodet-Milin C
    Nucl Med Commun; 2012 Oct; 33(10):1089-95. PubMed ID: 22929116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
    Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up.
    Ostermeier A; McCarville MB; Navid F; Snyder SE; Shulkin BL
    Pediatr Radiol; 2015 Aug; 45(9):1308-15. PubMed ID: 25721584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.